Literature DB >> 11551959

CARDINAL, a novel caspase recruitment domain protein, is an inhibitor of multiple NF-kappa B activation pathways.

L Bouchier-Hayes1, H Conroy, H Egan, C Adrain, E M Creagh, M MacFarlane, S J Martin.   

Abstract

Proteins possessing the caspase recruitment domain (CARD) motif have been implicated in pathways leading to activation of caspases or NF-kappaB in the context of apoptosis or inflammation, respectively. Here we report the identification of a novel protein, CARDINAL, that contains a CARD motif and also exhibits a high degree of homology to the C terminus of DEFCAP/NAC, a recently described member of the Apaf-1/Nod-1 family. In contrast with the majority of CARD proteins described to date, CARDINAL failed to promote apoptosis or NF-kappaB activation. Rather, CARDINAL potently suppressed NF-kappaB activation associated with overexpression of TRAIL-R1, TRAIL-R2, RIP, RICK, Bcl10, and TRADD, or through ligand-induced stimulation of the interleukin-1 or tumor necrosis factor receptors. Co-immunoprecipitation experiments revealed that CARDINAL interacts with the regulatory subunit of the IkappaB kinase (IKK) complex, IKKgamma (NEMO), providing a molecular basis for CARDINAL function. Thus, CARDINAL is a novel regulator of NF-kappaB activation in the context of pro-inflammatory signals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11551959     DOI: 10.1074/jbc.M107373200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Mutant human cells with constitutive activation of NF-kappaB.

Authors:  Swati S Sathe; Nywana Sizemore; Xiaoxia Li; Kalpa Vithalani; Mairead Commane; Shannon M Swiatkowski; George R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-22       Impact factor: 11.205

Review 2.  CARD games in apoptosis and immunity.

Authors:  Lisa Bouchier-Hayes; Seamus J Martin
Journal:  EMBO Rep       Date:  2002-07       Impact factor: 8.807

3.  Caspase recruitment domain-containing protein 8 (CARD8) negatively regulates NOD2-mediated signaling.

Authors:  Oliver von Kampen; Simone Lipinski; Andreas Till; Seamus J Martin; Wilfried Nietfeld; Hans Lehrach; Stefan Schreiber; Philip Rosenstiel
Journal:  J Biol Chem       Date:  2010-04-12       Impact factor: 5.157

Review 4.  Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation.

Authors:  L Ferrero-Miliani; O H Nielsen; P S Andersen; S E Girardin
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

Review 5.  The PYRIN domain in signal transduction.

Authors:  Christian Stehlik
Journal:  Curr Protein Pept Sci       Date:  2007-06       Impact factor: 3.272

Review 6.  NLR proteins: integral members of innate immunity and mediators of inflammatory diseases.

Authors:  Jeanette M Wilmanski; Tanja Petnicki-Ocwieja; Koichi S Kobayashi
Journal:  J Leukoc Biol       Date:  2007-09-17       Impact factor: 4.962

7.  The structure of the CARD8 caspase-recruitment domain suggests its association with the FIIND domain and procaspases through adjacent surfaces.

Authors:  Tengchuan Jin; Mo Huang; Patrick Smith; Jiansheng Jiang; T Sam Xiao
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-04-27

8.  Simvastatin reduces burn injury-induced splenic apoptosis via downregulation of the TNF-α/NF-κB pathway.

Authors:  Gaofeng Zhao; Yong-Ming Yu; Masao Kaneki; Ali A Bonab; Ronald G Tompkins; Alan J Fischman
Journal:  Ann Surg       Date:  2015-05       Impact factor: 12.969

Review 9.  Intracellular sensing of microbes and danger signals by the inflammasomes.

Authors:  Gabor L Horvath; Jacob E Schrum; Christine M De Nardo; Eicke Latz
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

10.  The inhibitor ABIN-2 disrupts the interaction of receptor-interacting protein with the kinase subunit IKKgamma to block activation of the transcription factor NF-kappaB and potentiate apoptosis.

Authors:  Wei-Kuang Liu; Pei-Fen Yen; Chia-Yi Chien; Ming-Ji Fann; Jin-Yuan Su; Chen-Kung Chou
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.